Abbott Laboratories Surges on 2026 Profit Guidance Raise
Guidance·3 articles across 3 outlets·↩ Updated
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Abbott Laboratories soared the most in 24 years after raising its 2026 profit guidance following a stronger-than-expected second quarter driven by improved performance across most of its business lines.
The company also reported better-than-expected second-quarter metrics, prompting the stock to jump early Thursday as it raised its 2026 profit view.
Abbott Laboratories
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Abbott Laboratories soared the most in 24 years after raising its 2026 profit guidance following a stronger-than-expected second quarter driven by improved performance across most of its business lines.”
Bloomberg — Abbott Laboratories Surges on 2026 Profit Guidance Raise“Abbott stock jumped early Thursday on better-than-expected second-quarter metrics.”
IBD — Abbott Bounds Higher After Hiking 2026 Profit View On Second-Quarter Beat
SupportCorroborates it
“Abbott posted stronger-than-expected profit and is raising its full-year earnings outlook”
quartz — Abbott posted stronger-than-expected profit and is raising its full-year earnings outlook
Earlier versions
- Jul 16, 11:41 AM — Abbott Raises 2026 Profit Guidance After Strong Second Quarter (1/1)